These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3157826)

  • 41. Factors influencing remission phase in children with type 1 diabetes mellitus.
    Büyükgebiz A; Cemeroglu AP; Böber E; Mohn A; Chiarelli F
    J Pediatr Endocrinol Metab; 2001; 14(9):1585-96. PubMed ID: 11795651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of insulin therapy on the immune status of patients with newly detected diabetes mellitus].
    Sliusarenko NS; Taranova NB
    Lik Sprava; 1994; (3-4):102-3. PubMed ID: 7975524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.
    Battaglia M; Roncarolo MG
    Semin Immunol; 2011 Jun; 23(3):182-94. PubMed ID: 21831659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunotherapy in type I diabetes. Approaches to prevention and treatment.
    Colman PG; Eisenbarth GS
    Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between islets and regulatory immune cells in health and type 1 diabetes.
    Budd MA; Monajemi M; Colpitts SJ; Crome SQ; Verchere CB; Levings MK
    Diabetologia; 2021 Nov; 64(11):2378-2388. PubMed ID: 34550422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.
    Woittiez NJ; Roep BO
    Immunotherapy; 2015; 7(2):163-74. PubMed ID: 25713991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Children with diabetes mellitus].
    Hulst SG
    Tijdschr Ziekenverpl; 1974 Jul; 27(29):700-5. PubMed ID: 4496161
    [No Abstract]   [Full Text] [Related]  

  • 48. New trends in diabetes research: the search for an etiologically oriented treatment for type I diabetes mellitus.
    Eizirik DL; Migliorini RH
    Braz J Med Biol Res; 1983 Dec; 16(4):381-3. PubMed ID: 6201223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy of insulin-dependent diabetes mellitus.
    Bach JF
    Curr Opin Immunol; 2001 Oct; 13(5):601-5. PubMed ID: 11544012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?
    Ludvigsson J
    Expert Rev Vaccines; 2012 Mar; 11(3):263-5. PubMed ID: 22380817
    [No Abstract]   [Full Text] [Related]  

  • 51. Innovative immunological strategies for type 1 diabetes.
    Vives-Pi M; Pujol-Autonell I
    Endocrinol Nutr; 2015 Nov; 62(9):419-21. PubMed ID: 26342847
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitamin D3 supplementation to preserve pancreatic β-cell function in newly diagnosed type 1 diabetic patients.
    Magge SN
    Arch Pediatr Adolesc Med; 2012 Jul; 166(7):664-6. PubMed ID: 22751886
    [No Abstract]   [Full Text] [Related]  

  • 53. [Ultrastructure of the peripheral blood lymphocytes in children with diabetes mellitus].
    Smiian AI; Smorshchok SA
    Probl Endokrinol (Mosk); 1984; 30(4):14-8. PubMed ID: 6473313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune Intervention for Type 1 Diabetes.
    Nambam B; Bratina N; Schatz D
    Diabetes Technol Ther; 2018 Feb; 20(S1):S86-S93. PubMed ID: 29437480
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune intervention studies in insulin-dependent diabetes mellitus.
    Skyler JS
    Diabetes Metab Rev; 1987 Oct; 3(4):1017-35. PubMed ID: 3315520
    [No Abstract]   [Full Text] [Related]  

  • 56. [Insulin resistance of immunological origin in an insulin-dependent diabetic patient].
    Coutarel P; Doumith R; Bosquet F; Grimaldi A
    Rev Med Interne; 1987; 8(5):534. PubMed ID: 3445036
    [No Abstract]   [Full Text] [Related]  

  • 57. Defining a cure for type 1 diabetes: a call to action.
    Roep BO; Montero E; van Tienhoven R; Atkinson MA; Schatz DA; Mathieu C
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):553-555. PubMed ID: 34339632
    [No Abstract]   [Full Text] [Related]  

  • 58. Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere?
    Lernmark Å
    Diabetes; 2013 Nov; 62(11):3669-70. PubMed ID: 24158996
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diabetes by immunotherapy].
    Manzano N; Ocampo P; Nicolini C; Halac S; Aguirre M; Rivero S; Zylberman M
    Medicina (B Aires); 2018; 78(1):60. PubMed ID: 29360082
    [No Abstract]   [Full Text] [Related]  

  • 60. [Immunotherapy of type 1 diabetes mellitus: current state-of-the-art and prospects. Part 2].
    Laptev DN
    Probl Endokrinol (Mosk); 2009 Oct; 55(5):31-38. PubMed ID: 31569853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.